Allara Secures $26M to Broaden Telehealth Services for Women’s Hormonal Health

Allara, a telehealth platform dedicated to addressing women’s hormonal health issues, has raised $26 million in Series B funding led by Index Ventures, with participation from GV. The company plans to use this capital to expand its reach, including extending insurance coverage nationwide, following significant revenue growth over the past year.

Allara Secures $26M to Broaden Telehealth Services for Women’s Hormonal Health
Rachel Blank, Founder of Allara

Allara, a telehealth platform dedicated to addressing women’s hormonal health issues, has raised $26 million in Series B funding led by Index Ventures, with participation from GV. The company plans to use this capital to expand its reach, including extending insurance coverage nationwide, following significant revenue growth over the past year.

Founded by Rachel Blank more than four years ago, Allara was born from Blank’s personal experience navigating a healthcare system that lacked specialized care for hormonal conditions. At the age of 21, Blank was diagnosed with polycystic ovary syndrome (PCOS), a condition that can lead to irregular periods, infertility, and weight gain. While Blank had access to excellent care, she realized that most OB-GYNs are not equipped to treat hormonal disorders comprehensively. “There weren’t a lot of places for me to go because the concept of a specialist for my condition didn’t exist,” Blank explained. Her experience of piecing together a treatment plan involving dieticians, endocrinologists, and other specialists inspired her to create a more unified solution.

Allara offers patients an integrated care model, allowing them to access multiple specialists in one platform. Initially operating on a subscription-based model, the company now collaborates with major insurance providers such as Aetna, Blue Cross Blue Shield, Cigna, Humana, and United Healthcare, covering its services in ten states. The recent funding will support the company’s efforts to bring these partnerships to a national scale.

The platform primarily serves women in their 20s and 30s, a demographic that typically seeks care for chronic conditions like PCOS, endometriosis, and hypothyroidism before pursuing family planning. Unlike other telehealth companies such as Tia, Midi Health, and Gennev, which focus on infertility or menopause, Allara addresses the needs of younger women who are navigating complex health issues.

Healthcare providers, including doctors, nurse practitioners, dermatologists, and registered dieticians, benefit from the platform’s remote model, enabling them to treat patients without traveling to physical clinics. Many of these professionals, often balancing demanding personal and professional lives, find the flexibility of Allara appealing.

According to Martin Mignot, a partner at Index Ventures, the platform’s potential for long-term patient relationships is a key draw. “If you have a relationship with your care providers since you are 20 or 25, it is very natural to stay over time,” Mignot said. This longevity could pave the way for Allara to expand into other areas of women’s health, including infertility and menopause.

With its latest round of funding, Allara aims to solidify its position as a leader in comprehensive hormonal care, addressing gaps in traditional healthcare and providing women with the support they need to manage chronic conditions effectively.